Hydroxyurea (Biosupressin-BIOGAL) for the treatment of chronic myelogenous leukaemia
Klener, P.; Donner, L.
Therapia Hungarica 29(1): 38-41
1981
ISSN/ISBN: 0133-3909 PMID: 6964902 Document Number: 181898
Document emailed within 1 workday
Related Documents
Van Rhee, F.; Lin, F.; Cross, N.C.; Reid, C.D.; Lakhani, A.K.; Szydlo, R.M.; Goldman, J.M. 1994: Detection of residual leukaemia more than 10 years after allogeneic bone marrow transplantation for chronic myelogenous leukaemia Bone Marrow Transplantation 14(4): 609-612Wöhrer, S.; Rabitsch, W.; Shehata, M.; Kondo, R.; Esterbauer, H.; Streubel, B.; Sillaber, C.; Raderer, M.; Jaeger, U.; Zielinski, C.; Valent, P. 2007: Mesenchymal stem cells in patients with chronic myelogenous leukaemia or bi-phenotypic Ph+ acute leukaemia are not related to the leukaemic clone Anticancer Research 27(6b): 3837-3841
Lisiewicz, J.; Malkiewicz-Wasowicz, B.; Biernacka, B. 1973: Thromboplastic activity of chronic myelogenous leukaemia granulocytes Folia Haematologica 99(1): 57-64
Shtivelman, E.; Lifshitz, B.; Gale, R.P.; Canaani, E. 1985: Fused transcript of abl and bcr genes in chronic myelogenous leukaemia Nature 315(6020): 550-554
Löwenberg, B. 1997: Treatment of acute myelogenous leukaemia Journal of Internal Medicine. Supplement 740: 17-22
Wu, H.K.; Heng, H.H.; Siderovski, D.P.; Dong, W.F.; Okuno, Y.; Shi, X.M.; Tsui, L.C.; Minden, M.D. 1996: Identification of a human LIM-Hox gene, hLH-2, aberrantly expressed in chronic myelogenous leukaemia and located on 9q33-34.1 Oncogene 12(6): 1205-1212
Garicochea, B.; Chase, A.; Lazaridou, A.; Goldman, J.M. 1994: T lymphocytes in chronic myelogenous leukaemia (CML): no evidence of the BCR/ABL fusion gene detected by fluorescence in situ hybridization in 14 patients Leukemia 8(7): 1197-1201
Nemet, D.; Labar, B.; Bogdanić, V.; Hauptman, E.; Jaksić, B.; Minigo, H.; Sertić, D.; Mrsić, M.; Pavletić, Z.; Kovacević, J. 1989: High dose cytosine arabinoside in the treatment of adult acute myelogenous leukaemia Bone Marrow Transplantation 4(Suppl 3): 42-44
Rozman, C.; Woessner, S. 1979: Chronic lymphosarcoma-cell leukaemia versus chronic lymphocytic leukaemia. Quantitative electron-microscopic study Sangre 24(4): 396-411
Melo, J.V.; Goldman, J.M. 1992: Specific point mutations that activate v-abl are not found in Philadelphia-negative chronic myeloid leukaemia, Philadelphia-negative acute lymphoblastic leukaemia or blast transformation of chronic myeloid leukaemia Leukemia 6(8): 786-790
Melo, J.V.; Myint, H.; Galton, D.A.; Goldman, J.M. 1994: P190BCR-ABL chronic myeloid leukaemia: the missing link with chronic myelomonocytic leukaemia? Leukemia 8(1): 208-211
Guilhot, F. 1994: The role of interferon in the treatment of chronic myelogenous leukemia in chronic phase Nouvelle Revue Francaise d'Hematologie 36(Suppl 1): S39-S46
Gorman, A.; Fennelly, J.J.; O'Connell, L.G. 1972: Intensive chemotherapy of acute myelogenous leukaemia Journal of the Irish Medical Association 65(20): 509-513
Jaiprakash, M.P.; Antia, P.K.; Shetty, P.A. 1981: Extramedullary deposits in acute myelogenous leukaemia Indian Journal of Cancer 18(1): 51-53
Quaglino, D.; Lusvarghi, E.; Piccinini, L.; di Prisco, A.U.; Guerzoni, O.; Mauri, C. 1976: The association between chronic lymphocytic leukaemia and a solid tumor: a survey study of 258 cases of chronic lymphocytic leukaemia covering an eleven year period Haematologica 61(4): 456-469
Guilhot, F. 1993: Interferon alfa and low-dose cytosine-arabinoside for the treatment of patients with chronic myelogenous leukemia in chronic phase. French CML Study Group Seminars in Hematology 30(3 Suppl 3: 24-25
Clift, R.A.; Buckner, C.D.; Thomas, E.D.; Doney, K.; Fefer, A.; Neiman, P.E.; Singer, J.; Sanders, J.; Stewart, P.; Sullivan, K.M.; Deeg, J.; Storb, R. 1982: Treatment of chronic granulocytic leukaemia in chronic phase by allogeneic marrow transplantation Lancet 2(8299): 621-623
Stopera, S.A.; Ray, M. 1989: Expression and distribution of aphidicolin-induced fragile sites in chronic myeloid leukaemia, acute lymphocytic leukaemia and acute myeloid leukaemia Cytobios 60(241): 103-109
Cortes, J. 2012: Bosutinib in the treatment of chronic myelogenous leukemia Clinical Advances in Hematology and Oncology: H&o 10(11): 736-737
Singh, V.P.; Rai, M.; Shukla, J.; Sunder, S.; Usha 2002: Chronic lymphocytic leukaemia terminating into plasma cell leukaemia Journal of the Association of Physicians of India 50: 840-841